← Back to Search

Device

Evalyn Brush for Human Papillomavirus

N/A
Waitlist Available
Led By Jennifer Moss, PhD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within two weeks of their colposcopy exam
Awards & highlights

Study Summary

This trial is testing whether a self-sampling HPV test is as accurate as a test done by a clinician, and also whether people find it acceptable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within two weeks of their colposcopy exam.
This trial's timeline: 3 weeks for screening, Varies for treatment, and within two weeks of their colposcopy exam. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Concordance of Screening Results of the Self-Sampling Kit Compared to Clinician-collected Samples
Secondary outcome measures
Number of Completed Self-Sampling Kits
Number of Participants Who Reported Problems Using Self-Sampling Kits

Trial Design

1Treatment groups
Experimental Treatment
Group I: Self-Sampling KitExperimental Treatment1 Intervention
Participants will be mailed a Self-Sampling kit (Evalyn Brush) to collect samples for analysis for HPV/Cervical cancer screening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Evalyn Brush
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
494 Previous Clinical Trials
2,798,820 Total Patients Enrolled
Jennifer Moss, PhDPrincipal InvestigatorPenn State College of Medicine
2 Previous Clinical Trials
94 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
CA: A Cancer Journal for CliniciansJournal
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
Saslow, Debbie, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini L. Kulasingam, Joanna Cain, Francisco A. R. Garcia, et al.. 2012. “American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer”. CA: A Cancer Journal for Clinicians. Wiley. doi:10.3322/caac.21139.
Nature Reviews Clinical OncologyJournal
Population-based Screening for Cancer: Hope and Hype
Shieh, Yiwey, Martin Eklund, George F. Sawaya, William C. Black, Barnett S. Kramer, and Laura J. Esserman. 2016. “Population-based Screening for Cancer: Hope and Hype”. Nature Reviews Clinical Oncology. Springer Science and Business Media LLC. doi:10.1038/nrclinonc.2016.50.
CA: A Cancer Journal for CliniciansJournal
Cancer Statistics, 2018
Siegel, Rebecca L., Kimberly D. Miller, and Ahmedin Jemal. 2018. “Cancer Statistics, 2018”. CA: A Cancer Journal for Clinicians. Wiley. doi:10.3322/caac.21442.
clinicaltrials.govStudy
Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy
Jennifer L. Moss, PhD 2020. "Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04585243.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top